Skip header and navigation

3 records – page 1 of 1.

Life after a heart attack

https://libcat.nshealth.ca/en/permalink/chpams34348
Nova Scotia Health Authority. Heart Health Portfolio. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
0016
Available Online
View Pamphlet
This pamphlet provides a comprehensive guide to answer questions you may have after experiencing a heart attack. Reducing the risk factors for heart disease, heart healthy eating, coping with emotions and stress, activity, medications and local resources are covered. Directions for managing chest pain and/or discomfort at home are given.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Heart Health Portfolio
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document (34 p.) : digital, PDF file
Subjects (MeSH)
Myocardial Infarction - prevention & control
Myocardial infarction - rehabilitation
Heart Diseases - prevention & control
Subjects (LCSH)
Myocardial infarction
Heart--Diseases--Patients--Rehabilitation
Specialty
Cardiovascular system
Abstract
This pamphlet provides a comprehensive guide to answer questions you may have after experiencing a heart attack. Reducing the risk factors for heart disease, heart healthy eating, coping with emotions and stress, activity, medications and local resources are covered. Directions for managing chest pain and/or discomfort at home are given.
Responsibility
Prepared by: Heart Health Portfolio, NSHA
Pamphlet Number
0016
Less detail

Management of Myocardial Reperfusion Injury

https://libcat.nshealth.ca/en/permalink/provcat31045
Juan Carlos Kaski ... [et al.], editors. --London: Springer , c2012.
Available Online
View e-Book
Location
Online
Much has been written about myocardial reperfusion injury and the controversies surrounding its existence and clinical relevance in the past 20 to 30 years. Unfortunately, however, there is little published information that integrates research findings with the practical aspects of its management and this has hindered the analysis of the clinical impact of the condition and its management. The pathophysiology and molecular mechanisms of myocardial reperfusion injury are complex, while individu…
Available Online
View e-Book
Other Authors
Kaski, Juan Carlos
Responsibility
Juan Carlos Kaski ... [et al.], editors
Place of Publication
London
Publisher
Springer
Date of Publication
c2012
Physical Description
1 online resource (xv, 305 p. : 55 ill., 28 ill. in color)
ISBN
9781849960199
Subjects (MeSH)
Myocardial Infarction - prevention & control
Myocardial Ischemia - prevention & control
Myocardial Reperfusion Injury - diagnosis
Myocardial Reperfusion Injury - physiopathology
Myocardial Reperfusion Injury - therapy
Subjects (LCSH)
Cardiology
Heart - Surgery
Abstract
Much has been written about myocardial reperfusion injury and the controversies surrounding its existence and clinical relevance in the past 20 to 30 years. Unfortunately, however, there is little published information that integrates research findings with the practical aspects of its management and this has hindered the analysis of the clinical impact of the condition and its management. The pathophysiology and molecular mechanisms of myocardial reperfusion injury are complex, while individual diagnostic techniques have been proposed but without a proper assessment of the relative values of these methods. The management of this condition has also been problematic, as therapeutic strategies that demonstrate prevention of myocardial reperfusion injury in experimental models have not translated into beneficial treatment strategies for patients. Management of Myocardial Reperfusion Injury brings together leading cardiovascular researchers and cardiologists to provide a comprehensive and critical review of the issues. Existing and novel therapeutic strategies for preventing myocardial reperfusion injury are discussed in depth, which will result in this being a vital reference for cardiologists and all healthcare professionals with an interest in the pathogenesis and management of myocardial damage. Cardiologists in training will find this monographic work to be an invaluable formative tool. This book will hopefully assist in further reducing the morbidity and mortality resulting from acute myocardial infarction.
Contents
Part I. Introduction -- 1. Myocardial Reperfusion Injury as a New Frontier for Clinical Therapy -- Part II. The Pathophysiology of Myocardial Reperfusion Injury: From a Pre-clinical Phenomenon to a New Target for Cardioprotection -- 2. Pathophysiology of Myocardial Reperfusion Injury -- 3. Microvascular Obstruction: The No-Reflow Phenomenon in Animal Models of Myocardial Ischemia and Reperfusion -- 4. Lethal Myocardial Reperfusion Injury -- 5. Translating Cardioprotective Strategies into Clinical Settings -- Part III. Diagnosis of Myocardial Reperfusion Injury: Assessment and Quantification -- 6. Cardiac Catheter Laboratory -- 7. Echocardiography in Myocardial Reperfusion Injury -- 8. Nuclear Imaging to Assess Infarction, Reperfusion, No-Reflow, and Viability -- 9. Role of Cardiovascular Magnetic Resonance in the Assessment of Patients with Acute Myocardial Infarction -- Part IV. Management of Myocardial Reperfusion Injury -- 10. Current Approaches to Prevention and Management of Reperfusion Injury -- 11. Endogenous Cardioprotective Strategies -- 12. Novel Treatment Strategies -- 13. Future Perspectives -- Index.
Format
e-Book
Location
Online
Less detail
Nova Scotia Health Authority. QEII. Cardiology. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1496
Available Online
View Pamphlet
Ticagrelor is a medicine used along with low dose Aspirin to reduce your risk of having a heart attack. You should not take Ticagrelor if you have or had a current bleeding problem such as bleeding from a stomach ulcer or if you have severe liver disease. Instructions for how to take and store this medicine as well as drug interactions and foods to avoid are discussed. Missed dose instructions are given. This pamphlet also describes warnings and possible side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Cardiology
Alternate Title
Brilinta
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Platelet Aggregation Inhibitors - therapeutic use
Adenosine - therapeutic use
Cardiovascular Diseases - prevention & control
Myocardial Infarction - prevention & control
Pulmonary Embolism - prevention & control
Subjects (LCSH)
Adenosine
Anticoagulants (Medicine)
Cardiovascular system--Diseases--Prevention
Myocardial infarction--Prevention
Abstract
Ticagrelor is a medicine used along with low dose Aspirin to reduce your risk of having a heart attack. You should not take Ticagrelor if you have or had a current bleeding problem such as bleeding from a stomach ulcer or if you have severe liver disease. Instructions for how to take and store this medicine as well as drug interactions and foods to avoid are discussed. Missed dose instructions are given. This pamphlet also describes warnings and possible side effects.
Responsibility
Prepared by: Cardiology
Pamphlet Number
1496
Less detail